Santhera Broadens Biomedica Partnership For AGAMREE® Distribution In Central Asia & The Caucasus
Pratteln, Switzerland, July 13, 2026. Santhera Pharmaceuticals (SIX: SANN) has announced an extension of its exclusive distribution partnership with Biomedica for AGAMREE® (vamorolone). The expanded agreement adds Georgia, Kazakhstan, Belarus, Azerbaijan, and Uzbekistan to the territories covered by the collaboration. AGAMREE® is intended for the treatment of Duchenne muscular dystrophy (DMD) in patients aged two … Read more
